Keywords: عامل اختلال عروقی; Microtubule destabilizing agents; Esophageal squamous cell carcinoma; Antitumor effect; Apoptosis; Vascular disrupting agents; AC-α-tubulin; acetylated-α-tubulin; CA4; combretastatin A-4; DAPI; 6-diamidino-2-phenylindole; ESCC; esophageal squamous cell
مقالات ISI عامل اختلال عروقی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: عامل اختلال عروقی; ALK1; activin receptor-like kinase1; ANG/Ang; angiopoietin; Bcl-xL; b-cell lymphoma-extra large; BM; bone marrow; BMDCs; bone marrow derived cells; BMP; bone morphogenetic protein; Bv8; bombina variagata peptide 8; CAFs; cancer/carcinoma associated fibrob
Keywords: عامل اختلال عروقی; Small-molecule synthesis; Inhibitors of tubulin polymerization; Vascular disrupting agents; Amino acid prodrug salts; Anti-cancer agents; Combretastatin analogs; Benzosuberene analogs; Dihydronaphthalene analogs
Keywords: عامل اختلال عروقی; Vascular disrupting agents; Angiogenesis; Combretastatin; Tubulin binding agents; HUVEC;
Keywords: عامل اختلال عروقی; Inhibitors of tubulin polymerization; Benzosuberene analogues; Vascular disrupting agents; Small-molecule synthesis;
Synthesis and biological evaluation of carbamates derived from aminocombretastatin A-4 as vascular disrupting agents
Keywords: عامل اختلال عروقی; Tubulin; Aminocombretastatin; Microtubules; Carbamates; Vascular disrupting agents; Apoptosis;
Conformational mimetics of the α-methyl chalcone TUB091 binding tubulin: Design, synthesis and antiproliferative activity
Keywords: عامل اختلال عروقی; Tubulin; Chalcones; Antiproliferative activity; Molecular modeling; CA1; combretastatin A1; CA2; combretastatin A2; CA4; combretastatin A4; CA4P; combretastatin A4 phosphate; R-PT; (R)-(+)-ethyl 5-amino 2-methyl-1,2-dihydro-3-phenylpyrido[3,4-b]pyrazin-7-
Full length articleA poly(l-glutamic acid)-combretastatin A4 conjugate for solid tumor therapy: Markedly improved therapeutic efficiency through its low tissue penetration in solid tumor
Keywords: عامل اختلال عروقی; Vascular disrupting agents; Combretastatin A4; Nanomedicine; Tumor therapy; Delivery; Glutamic acid;
Enhanced anticancer effect of Combretastatin A-4 phosphate when combined with vincristine in the treatment of hepatocellular carcinoma
Keywords: عامل اختلال عروقی; Combretastatin; Hepatic cancer; Tubulin; Vincristine; Vascular disrupting agents;
Real-time monitoring of circulating tumor cell (CTC) release after nanodrug or tumor radiotherapy using in vivo flow cytometry
Keywords: عامل اختلال عروقی; Radiation; TNF-α; Vascular disrupting agents; Circulating tumor cells; Metastasis; In vivo fluorescent flow cytometry;
Design, synthesis, and biological evaluation of cyclic-indole derivatives as anti-tumor agents via the inhibition of tubulin polymerization
Keywords: عامل اختلال عروقی; Cyclic-indole derivatives; Antiproliferative activity; Tubulin polymerization inhibitor; Cell cycle arrest; Apoptosis; CA-4; Combretastain A-4; VDAs; vascular disrupting agents; HMTA; hexamethylenetetramine; HUVECs; human umbilical vein endothelial cells;
CA-1H, a novel oxazole bearing analogue of combretastatin A-4, disrupts the tumor vasculatures and inhibits the tumor growth via inhibiting tubulin polymerization
Keywords: عامل اختلال عروقی; Tumor; Vascular disrupting agents; Combretastatin A-4; Oxazole
Vascular priming enhances chemotherapeutic efficacy against head and neck cancer
Keywords: عامل اختلال عروقی; Head and neck squamous cell carcinoma; Angiogenesis; Vascular targeting; Vascular disrupting agents;
Vascular disrupting effects of combretastatin A4 phosphate on murine endometriotic lesions
Keywords: عامل اختلال عروقی; Endometriosis; combretastatin A4 phosphate (CA4P); vascular disrupting agents; angiogenesis; vascularization;
Synthesis and biological evaluation of enantiomerically pure cyclopropyl analogues of combretastatin A4
Keywords: عامل اختلال عروقی; Vascular disrupting agents; Tubulin; Combretastatin; Cyclopropyl compounds; Palladium catalyzed reactions
Combination of vascular disrupting agents and ionizing radiation
Keywords: عامل اختلال عروقی; Vascular disrupting agents; Radiotherapy; CA-4-P; Tubulin binding agents; Antiangiogenic agents; Preclinical rationale
Liposomes as carriers for colchicine-derived prodrugs: Vascular disrupting nanomedicines with tailorable drug release kinetics
Keywords: عامل اختلال عروقی; Liposomes; Colchicine; Colchicinoids; Cancer; Prodrugs; Vascular disrupting agents
Support of a free radical mechanism for enhanced antitumor efficacy of the microtubule disruptor OXi4503
Keywords: عامل اختلال عروقی; OXi4503; Combretastatin; Vascular disrupting agents; Endothelial cells; Magnetic resonance imaging; Viable rim; Tubulin-binding agents
Synthesis, in vitro and in vivo preliminary evaluation of anti-angiogenic properties of some pyrroloazaflavones
Keywords: عامل اختلال عروقی; Pyrroloazaflavones; Phenyl-pyrroloquinolinones; Angiogenesis; Anti-vascular agents; ECs; endothelial cells; HUVECs; human umbilical vein ECs; MTD; maximum tolerated dose; SARs; structure-activity relationships; VTAs; vascular targeting agents; VDAs; vas
Antiangiogenic Agents and Vascular Disrupting Agents for the Treatment of Lung Cancer: A Review
Keywords: عامل اختلال عروقی; Lung cancer; Antiangiogenic agents; Vascular disrupting Agents
Design, synthesis and biological evaluation of dihydronaphthalene and benzosuberene analogs of the combretastatins as inhibitors of tubulin polymerization in cancer chemotherapy
Keywords: عامل اختلال عروقی; Benzosuberenes; Dihydronaphthalenes; Combretastatins; Tubulin; Vascular disrupting agents; Cancer Chemotherapy
Vascular Damaging Agents
Keywords: عامل اختلال عروقی; Angiogenesis inhibitors; chemotherapy; combretastatin; radiobiology; radiotherapy; vascular disrupting agents;
Design, synthesis, and biological evaluation of combretastatin nitrogen-containing derivatives as inhibitors of tubulin assembly and vascular disrupting agents
Keywords: عامل اختلال عروقی; Combretastatin; Tubulin; Inhibitors of tubulin assembly; Anti-cancer; Pro-drug constructs; Vascular disrupting agents